LIFT Intervention in Liver Transplant Candidates
Home-based Physical Therapy Intervention to Decrease Frailty in Liver Transplant Candidates
1 other identifier
interventional
500
1 country
1
Brief Summary
Frailty is a significant problem in patients undergoing liver transplant and is associated with poor outcomes and survival. Hence, optimizing physical fitness and counteracting frailty is important. However, many interventions are very resource intensive and therefore not feasible. In this study, the investigators aim to test the effectiveness of a newly designed intervention to improve frailty in liver transplant candidates. The "LIver FrailTy" intervention (LIFT) will consist of an evaluation by a physical therapist, an individualized home exercise prescription (HEP), exercise tracking using a smart phone application, daily text reminders to exercise and recurrent telephone check-ins. The investigators also aim to perform "Realistic Effort Action Planning" (REAP), which is a form of personality-informed motivational interviewing, in a subset of patients to determine if this enhances the LIFT intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 5, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedFebruary 13, 2023
February 1, 2023
4.8 years
April 5, 2021
February 10, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Frailty
Frailty is described as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. This outcome is measured by the Liver frailty index \[LFI\]. LFI is composed of 3 performance-based tests (grip strength, chair stands, and balance). There is no data to date describing the expected range of values. Higher LFI scores indicate a higher degree of frailty.
Every month for up to 5 years
Placement on liver transplant waitlist
A clinical measure for the participant and where they are located on the liver transplant waiting list.
Every month for up to 5 years
Clinical Outcomes - waitlist / post-transplant mortality
Measured if a patient dies while listed on the transplant waitlist or post-transplant.
Every month for up to 5 years
Clinical Outcomes - post transplant disposition
Determined by location of patient after transplant (can be listed such as acute rehabilitation, subacute rehabilitation center, home, etc.)
Every month for up to 5 years
Clinical Outcomes - number and duration of hospitalizations
Clinical measure for how many times a patient is hospitalized and how long those hospitalizations last.
Every month for up to 5 years
Clinical Outcomes - liver related complications
Data collected from medical chart for liver related complications including but not limited to diagnosis of: ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome, hepatopulmonary syndrome, infection.
Every month for up to 5 years
Secondary Outcomes (5)
Endurance
Every 3 months for up to 5 years
Patient adherence
Every week for up to 5 years
Degree of hepatic encephalopathy
Every 3 months for up to 5 years
Patient-reported quality of life
Every 3 months for up to 5 years
Personality assessment
Every month for up to 5 years
Study Arms (2)
LIFT subgroup
EXPERIMENTALPT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members.
LIFT + REAP subgroup
EXPERIMENTALPT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. We will also employ "Realistic Effort Action Planning" (REAP), a form of personality-informed motivational interviewing in a subset of patients to potentially enhance patient engagement and adherence to the home-exercise prescription.
Interventions
Novel physical therapy intervention to decrease frailty in pre-transplant patients
This intervention is an interactive behavioral interviewing process to engage patients in their care
Eligibility Criteria
You may qualify if:
- Patients with a diagnosis of liver cirrhosis being evaluated for liver transplantation in hepatology/transplant evaluation clinic
- English-speaking
- Patients with access to a smart phone (with videoconference capabilities)
- Vulnerable populations: We will include patients who are cognitively impaired due to hepatic encephalopathy and unable to consent for themselves.
You may not qualify if:
- Patients \< 18 years of age
- Patients who require outpatient physical therapy.
- Patients without the ability to consent for themselves or through a medical power of attorney.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Medicine
Chicago, Illinois, 60611, United States
Related Publications (1)
Thuluvath AJ, Polineni P, Morrissey S, Belfanti K, Nizamuddin M, Siddiqui O, Daud A, Simpson DC, Levitsky J, Flores AM, Duarte-Rojo A, Ladner DP. Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study. Transplantation. 2025 Apr 1;109(4):e202-e212. doi: 10.1097/TP.0000000000005263. Epub 2024 Nov 6.
PMID: 40131764DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniela Ladner, MD
Northwestern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery - Organ Transplantation
Study Record Dates
First Submitted
April 5, 2021
First Posted
April 8, 2021
Study Start
October 1, 2020
Primary Completion
July 31, 2025
Study Completion
September 1, 2025
Last Updated
February 13, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share